Integra LifeSciences (NASDAQ: IART) reported Q1 EPS of $0.76, $0.13 better than the analyst estimate of $0.63. Revenue for the quarter came in at $233.7 million versus the consensus estimate of $229.69 million.

Integra LifeSciences sees FY2015 EPS of $3.15-$3.33, versus the consensus of $3.17. Integra LifeSciences sees FY2015 revenue of $965-980 million, versus the consensus of $972.3 million.

For earnings history and earnings-related data on Integra LifeSciences (IART) click here.

Earnings Guidance

Wells Fargo Upgrades Integra LifeSciences (IART) to OutperformMay 1, 2015 6:48 AM Integra LifeSciences (IART) Appoints New CEOApril 30, 2015 4:28 PM Form 8-K INTEGRA LIFESCIENCES For: Apr 30April 30, 2015 4:12 PM Form 8-K INTEGRA LIFESCIENCES For: Apr 30April 30, 2015 4:09 PM Integra LifeSciences Names Keith Valentine as Chief Executive Officer of SeaSpine; John Bostjancic Appointed as Chief Financial Officer of SeaSpineApril 30, 2015 4:07 PM Integra LifeSciences Reports First Quarter 2015 Financial ResultsApril 30, 2015 4:07 PM